Skip to content

Fine-Tuning of a Specialized LLM Model for Multiple System Atrophy (MSA) Diagnosis and Management

Fine-Tuning of a Specialized LLM Model for Multiple System Atrophy (MSA) Diagnosis and Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129314
Enrollment
Unknown
Registered
2026-08-03
Start date
2026-03-18
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple system atrophy

Interventions

Gold Standard:Clinically established multiple system atrophy (MSA) according to the International Parkinson and Movement Disorder Society (MDS) clinical diagnostic criteria for MSA (2022) and the Chin
Index test:Neurological Disease Multiple System Atrophy (MSA) Diagnosis and Treatment Model

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Retrospective inclusion criteria: (1) Age 30 years and older; (2) Hospitalized patients with clinically established or clinically probable multiple system atrophy (MSA); (3) Patients meeting the criteria for clinically established MSA according to the International Parkinson and Movement Disorder Society clinical diagnostic criteria for multiple system atrophy (2022) and the Chinese Expert Consensus on Diagnostic Criteria for Multiple System Atrophy (2022). 2.Prospective inclusion criteria: (1) Age 30 years and older; (2) Hospitalized patients with clinically established or clinically probable multiple system atrophy (MSA); (3) Patients meeting the criteria for clinically established MSA according to the International Parkinson and Movement Disorder Society (MDS) clinical diagnostic criteria for multiple system atrophy (2022) and the Chinese Expert Consensus on Diagnostic Criteria for Multiple System Atrophy (2022); (4) Patient or legal guardian able to understand the study content and provide informed consent; (5) Clinically stable condition and able to comply with the study procedures.

Exclusion criteria

Exclusion criteria: 1.Retrospective exclusion criteria: (1) Medical records altered or obliterated, rendering information unreadable or uninterpretable; (2) Examination reports smudged, obliterated, or damaged, making recognition by the large model difficult or impossible; (3) Patients with comorbid severe psychiatric disorders (e.g., depression, mania, epileptic seizures, schizophrenia, etc.); (4) Cases with severe missing or incomplete clinical information. 2.Prospective exclusion criteria: (1) Patients with comorbid severe psychiatric disorders (e.g., depression, mania, epileptic seizures, schizophrenia, etc.); (2) Patients deemed by the investigator unable to cooperate with or complete the study procedures; (3) Patients with strong accent or poor audio recording quality that prevents accurate information extraction or recognition; (4) Examination reports smudged, obliterated, or damaged, rendering recognition by the large model difficult or impossible.

Design outcomes

Primary

MeasureTime frame
Percentage score for each case's diagnostic and treatment task (range: 0–100 points);

Secondary

MeasureTime frame
85% accuracy on the MSA medical record generation task;Physician subjective satisfaction score with system use (range: 0–100 points);

Countries

China

Contacts

Public ContactDingYan

Xuanwu Hospital Capital Medical University

dingding13001300@126.com+86 18633889260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026